Karoo Health Raises $16.2M Series A for AI-Native Cardiovascular Platform

Karoo Health announced $16.2M in Series A financing on July 21, 2026. Karoo Health raised a $16.2 million Series A co-led by 7wire Ventures and Allumia Ventures to develop its AI-native cardiovascular platform.

Round details

The financing includes backing from 7wire Ventures, Allumia Ventures, First Trust Capital Partners, SpringRock Ventures, Hyde Park Angels. The company did not publish a valuation with the announcement.

Round: Series A
Capital announced: $16.2M

How the company plans to use the capital

Karoo said it will use the proceeds to further develop its AI-native cardiovascular platform, expand its engineering and clinical teams, and scale deployments with payer and provider partners.

Why this matters for GTM teams

Karoo says its platform connects clinical, claims, pharmacy, and patient data, and that it supports a network of more than 600 cardiology providers across 11 states.

Fresh capital is often an operational signal rather than a buying signal by itself. Teams should validate the company’s hiring pattern, product launches, geographic expansion, and technology priorities before choosing the message and timing of outreach.

Source and methodology

This report is based on the company’s announcement and records the disclosed amount, round, investors, location, and stated use of funds. SalesTools Research does not estimate undisclosed valuation or revenue figures.

Primary source: Karoo Health Series A announcement.